NYSE · Medical - Distribution
Guardian Pharmacy Services, Inc. (GRDN) Stock
$41.60
+2.26%
NYSE: GRDN
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Business Wire · Jul 15, 2026
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last?
Zacks · Jul 8, 2026
Guardian Pharmacy Services Acquires Wellness Concepts in Virginia
MT Newswires · Jul 1, 2026
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Business Wire · Jul 1, 2026
Zacks.com featured highlights include Casey's General Stores, Everus Construction, Guardian Pharmacy Services, Expeditors International of Washington and Mama's Creations
Zacks · Jun 30, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held37.52%
Institutions Held58.96%
Institutions Float Held94.36%
Peer Comparison
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc. (GRDN) stock trades at $41.60 with a market capitalization of $2.63B. The stock is valued at a price-to-earnings (P/E) ratio of 40.36, price-to-book of 10.93, price-to-sales of 1.83. Over the past 52 weeks the stock has ranged between $23.14 and $48.33, and currently trades 13.9% below its 52-week high.
On profitability, Guardian Pharmacy Services, Inc. generates a return on equity (ROE) of 30.80% — well above the market average, a sign of a high-quality business, return on capital employed of 31.69%, an operating margin of 5.04%, a net profit margin of 4.50%.